MSP-2 K1 13/3
Polley SD, Conway DJ, Cavanagh DR, McBride JS, Lowe BS, Williams TN, Mwangi
TW, Marsh K. High levels of serum antibodies to merozoite surface protein 2 of
Plasmodium falciparum are associated with reduced risk of clinical malaria in
coastal Kenya. Vaccine. 2006 May 8;24(19):4233-46.
Please state in any acknowledgements, "Recombinant Plasmodium protein MSP-2 K1 13/3 was obtained from The European Malaria Reagent Repository (http://www.malariaresearch.eu)". It is a condition of the supply of this reagent that you also cite the reference and source given above in any publication.